LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION PATIENTS1

Bone marrow transplant

1989 • 3,423 citations

Bone marrow transplant

1999 • 2,452 citations

Modulation of endothelial cell hemostatic properties by tumor necrosis factor.

1986 • 1,335 citations

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1994 • 1,081 citations

Low molecular weight heparin

1992 • 921 citations

VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION

1987 • 898 citations

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1984 • 845 citations

Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis

1992 • 702 citations

Low molecular weight heparin

1992 • 657 citations

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1992 • 599 citations

Subcutaneous Low-Molecular-Weight Heparin Compared With Continuous IntravenoUnfractionated Unfractionated Heparin in the Treatment of Proximal Deep Vein Thrombosis

1993 • 239 citations

Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.

1992 • 226 citations

Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study

1985 • 223 citations

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

1985 • 191 citations

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

1992 • 190 citations

Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin

1990 • 188 citations

Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules.

1987 • 184 citations

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172

1989 • 174 citations

Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial [see comments]

1992 • 163 citations

Hepatic veno-occlusive disease

1986 • 143 citations

Efficacy and Safety of Enoxaparin to Prevent Deep Venous Thrombosis after Hip Replacement Surgery

1994 • 123 citations

Veno-Occlusive Disease of the Liver After Allogeneic Bone Marrow Transplantation

1979 • 94 citations

ORG 10172: a low molecular weight heparinoid anticoagulant with a long half‐life in man.

1987 • 69 citations

Enoxaparin

1992 • 64 citations

A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation.

1990 • 62 citations

HEPATIC DYSFUNCTION FOLLOWING T-CELL-DEPLETED ALLOGENEIC BONE MARROW TRANSPLANTATION

1991 • 54 citations

Fraxiparin, a low‐molecular‐weight heparin, stimulates megakaryocytopoiesis in vitro and in vivo in mice

1994 • 40 citations

Frequency of Veno-occlusive Disease of the Liver in Bone Marrow Transplantation with a Modified Busulfan/Cyclophosphamide Preparative Regimen

1990 • 34 citations

Endothelium and the Regulation of Coagulation

1986 • 16 citations